Literature DB >> 28264807

Unusual presentation of a late-onset recurrence of malignant peritoneal mesothelioma.

Marije Wijnberge1, Lidewine Daniels2, Vincent Cliteur3, Jasper Winkelhagen2.   

Abstract

A man aged 79 years with a history of malignant peritoneal mesothelioma presented 8 years after primary presentation with a suspected right-sided painful inguinal hernia and hydrocele, both present for 5 months. During surgery, however, the inguinal swelling appeared to be a tumour. Laboratory examination was non-alarming and ultrasonography not specific for mesothelioma. Pathological examination showed it to be a recurrence of the malignant mesothelioma, which was treated palliative with radiotherapy. This clinical picture is rare and a recurrence-free survival of 8 years is remarkable. 2017 BMJ Publishing Group Ltd.

Entities:  

Mesh:

Year:  2017        PMID: 28264807      PMCID: PMC5353370          DOI: 10.1136/bcr-2016-218573

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  11 in total

Review 1.  Primary peritoneal mesothelioma: case series and literature review.

Authors:  H Sharma; I Bell; J Schofield; G Bird
Journal:  Clin Res Hepatol Gastroenterol       Date:  2011-01       Impact factor: 2.947

Review 2.  Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for malignant peritoneal mesothelioma: a systematic review and meta-analysis.

Authors:  Joseph H Helm; John T Miura; Jason A Glenn; Rebecca K Marcus; Gregory Larrieux; Thejus T Jayakrishnan; Amy E Donahue; T Clark Gamblin; Kiran K Turaga; Fabian M Johnston
Journal:  Ann Surg Oncol       Date:  2014-08-15       Impact factor: 5.344

3.  Iterative cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for recurrent or progressive diffuse malignant peritoneal mesothelioma: clinicopathologic characteristics and survival outcome.

Authors:  Chukwuemeka Ihemelandu; Lana Bijelic; Paul H Sugarbaker
Journal:  Ann Surg Oncol       Date:  2014-08-14       Impact factor: 5.344

4.  Diffuse malignant peritoneal mesothelioma: long-term survival with complete cytoreductive surgery followed by hyperthermic intraperitoneal chemotherapy (HIPEC).

Authors:  Dario Baratti; Shigeki Kusamura; Antonello Domenico Cabras; Rossella Bertulli; Ionut Hutanu; Marcello Deraco
Journal:  Eur J Cancer       Date:  2013-07-04       Impact factor: 9.162

5.  Primary malignant peritoneal mesothelioma in an incarcerated groin hernia: report of a case.

Authors:  Mario Testini; Anna Scattone; Beatrice Di Venere; Germana Lissidini; Giuseppe Piccinni; Silvia Palmisano; Gabriella Serio
Journal:  Surg Today       Date:  2005       Impact factor: 2.549

Review 6.  Advances in malignant peritoneal mesothelioma.

Authors:  Shoubo Cao; Shi Jin; Jingyan Cao; Jing Shen; Jing Hu; Dehai Che; Bo Pan; Jiawen Zhang; Xiaoxi He; Dian Ding; Feifei Gu; Yan Yu
Journal:  Int J Colorectal Dis       Date:  2014-10-21       Impact factor: 2.571

Review 7.  Recurrent peritoneal mesothelioma with long-delayed recurrence.

Authors:  A Tandar; G Abraham; J Gurka; M Wendel; L Stolbach
Journal:  J Clin Gastroenterol       Date:  2001-09       Impact factor: 3.062

8.  A novel tumor-node-metastasis (TNM) staging system of diffuse malignant peritoneal mesothelioma using outcome analysis of a multi-institutional database*.

Authors:  Tristan D Yan; Marcello Deraco; Dominique Elias; Olivier Glehen; Edward A Levine; Brendan J Moran; David L Morris; Terence C Chua; Pompiliu Piso; Paul H Sugarbaker
Journal:  Cancer       Date:  2010-11-18       Impact factor: 6.860

9.  Characterization of a complex chromosome aberration in two cases of peritoneal mesothelioma arising primarily in the hernial sac.

Authors:  Gabriella Serio; Mattia Gentile; Antonio Pennella; Andrea Marzullo; Antonia Lucia Buonadonna; Pietro Nazzaro; Mario Testini; Marina Musti; Anna Scattone
Journal:  Pathol Int       Date:  2009-06       Impact factor: 2.534

10.  Guidelines for pathologic diagnosis of malignant mesothelioma: 2012 update of the consensus statement from the International Mesothelioma Interest Group.

Authors:  Aliya N Husain; Thomas Colby; Nelson Ordonez; Thomas Krausz; Richard Attanoos; Mary Beth Beasley; Alain C Borczuk; Kelly Butnor; Philip T Cagle; Lucian R Chirieac; Andrew Churg; Sanja Dacic; Armando Fraire; Francoise Galateau-Salle; Allen Gibbs; Allen Gown; Samuel Hammar; Leslie Litzky; Alberto M Marchevsky; Andrew G Nicholson; Victor Roggli; William D Travis; Mark Wick
Journal:  Arch Pathol Lab Med       Date:  2012-08-28       Impact factor: 5.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.